Table 2.
Characteristics of included studies.
Author. Year | Race | Participants | Number | Blood sample | Gender (Male/Female) |
Age | BMI | Ghrelin |
---|---|---|---|---|---|---|---|---|
Changzhen Zhu et al., 2020 | Asian | Controls | 69 | Serum | Unspecified | Unspecified | Unspecified | 19 ± 5.8 |
Qi Huang-Yue et al., 2007 | Asian | Controls | 24 | Plasma | 18/6 | 56.7 ± 12 | 24.1 ± 3.8 | 91.4 ± 73.6 |
Natalie R. Pritchett et al., 2020 | Asian | Controls | 770 | Plasma | 255/515 | 51 ± 9 | 22.1 ± 2.6 | 1022 ± 386 |
Natalie R. Pritchett et al., 2020 | Asian | Controls | 498 | Plasma | Unspecified | 58 ± 9 | 24.8 ± 3.6 | 743 ± 245 |
Hai-Tao Wang et al., 2008 | Asian | Controls | 20 | Plasma | 8/12 | 40.4 ± 10.2 | 22.2 ± 2.2 | 472 ± 115.9 |
Anna Zub-Pokrowiecka et al., 2011 | European | Controls | 25 | Plasma | 12/13 | 49.3 ± 11.5 | 23.8 ± 2.7 | 302.7 ± 76.7 |
Krike P. et al., 2018 | European | Controls | 246 | Plasma | Unspecified | Unspecified | Unspecified | 545.9 ± 275.1 |
O Kemik et al., 2011 | European | Controls | 40 | Plasma | 22/18 | 40.4 ± 11.3 | 21.5 ± 2.0 | 1104.3 ± 201.3 |
Hajime Isomoto et al., 2005 | Asian | Controls | 39 | Plasma | 16/23 | 51 | 22.6 | 174.8 ± 125.1 |
Hye-Kyung Jung et al., 2022 | Asian | Controls | 14 | Plasma | 7/7 | 49.6 ± 5.8 | 22.5 ± 2.3 | 555.8 ± 98.4 |